Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-sldb
/
Solid Biosciences Inc
SLDB
Add to Watchlist
10.840
USD
+0.640
+6.27%
Close 07/02, 13:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
After-hours 07/02, 17:00 (ET)
1.07B
Market Cap
Loss
P/E TTM
Solid Biosciences Inc
10.840
+0.640
+6.27%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Perceptive Advisors LLC
12.09%
RA Capital Management, LP
9.11%
Invus Public Equities Advisors, LLC
7.81%
Vestal Point Capital, LP
5.91%
Bain Capital Life Sciences Investors, LLC
4.58%
Other
60.50%
Shareholders
Shareholders
Proportion
Perceptive Advisors LLC
12.09%
RA Capital Management, LP
9.11%
Invus Public Equities Advisors, LLC
7.81%
Vestal Point Capital, LP
5.91%
Bain Capital Life Sciences Investors, LLC
4.58%
Other
60.50%
Shareholder Types
Shareholders
Proportion
Investment Advisor
22.45%
Hedge Fund
18.03%
Investment Advisor/Hedge Fund
17.18%
Private Equity
12.10%
Venture Capital
9.15%
Research Firm
2.72%
Individual Investor
0.96%
Bank and Trust
0.09%
Pension Fund
0.04%
Other
17.29%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
271
83.89M
85.25%
-13.75M
2025Q4
258
82.70M
106.15%
-17.44M
2025Q3
245
82.26M
105.58%
-6.26M
2025Q2
237
81.08M
104.59%
+27.37M
2025Q1
237
79.86M
103.02%
+25.88M
2024Q4
198
36.85M
67.00%
-4.80M
2024Q3
199
36.30M
93.97%
-4.52M
2024Q2
188
37.99M
98.93%
-1.65M
2024Q1
182
35.35M
93.37%
+4.46M
2023Q4
181
16.93M
83.83%
-1.01M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Perceptive Advisors LLC
11.83M
15.19%
-73.11K
-0.61%
Sep 30, 2025
RA Capital Management, LP
5.81M
7.46%
--
--
Sep 30, 2025
Invus Public Equities Advisors, LLC
7.42M
9.52%
--
--
Sep 30, 2025
Vestal Point Capital, LP
2.98M
3.82%
+1.47M
+97.67%
Sep 30, 2025
Bain Capital Life Sciences Investors, LLC
7.91M
10.15%
--
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
4.06M
5.21%
-309.31K
-7.08%
Sep 30, 2025
Citadel Advisors LLC
2.59M
3.33%
+69.40K
+2.75%
Sep 30, 2025
Armistice Capital LLC
936.00K
1.2%
+536.00K
+134.00%
Sep 30, 2025
Point72 Asset Management, L.P.
1.33M
1.71%
+66.95K
+5.29%
Sep 30, 2025
Fidelity Management & Research Company LLC
2.91M
3.74%
-264.27K
-8.31%
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
iShares Neuroscience and Healthcare ETF
0.52%
iShares Micro-Cap ETF
0.06%
ProShares Ultra Nasdaq Biotechnology
0.04%
Invesco Nasdaq Biotechnology ETF
0.04%
iShares Biotechnology ETF
0.03%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
iShares Russell 2000 Value ETF
0.02%
Avantis US Small Cap Equity ETF
0.02%
iShares Russell 2000 ETF
0.01%
ProShares UltraPro Russell2000
0.01%
View more
iShares Neuroscience and Healthcare ETF
Proportion
0.52%
iShares Micro-Cap ETF
Proportion
0.06%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.04%
Invesco Nasdaq Biotechnology ETF
Proportion
0.04%
iShares Biotechnology ETF
Proportion
0.03%
Invesco RAFI US 1500 Small-Mid ETF
Proportion
0.02%
iShares Russell 2000 Value ETF
Proportion
0.02%
Avantis US Small Cap Equity ETF
Proportion
0.02%
iShares Russell 2000 ETF
Proportion
0.01%
ProShares UltraPro Russell2000
Proportion
0.01%